
Triple-Negative Breast Cancer and the Application of Breast Cancer Organoid Models for Therapeutic Development
In our previous article, we outlined the main in vitro liver models, immortalized cell lines such
In our previous article, we outlined the main in vitro liver models, immortalized cell lines such
Obesity and its related metabolic diseases, such as type 2 diabetes, represent a growing global health
Authors: Priyanka Fernandes, Harry Dawson, Ethan N.P Vong, Pierre Savagner, Dario Fassini Breast cancer remains
Authors: Mathilde Cadoux, PhD; Emilie Ouanounou; Ghofrane Ben Messaoud; Hadhemi Mejri; Julius Elliot Nyegaard Grothen, PhD;
In our previous article, we outlined the main in vitro liver models, immortalized cell lines such
In vitro liver models are central to drug discovery and toxicology, enabling controlled evaluation of metabolism,
Liver disease and drug-induced liver injury remain critical challenges in medicine and pharmaceutical development, demanding models
Re-Engineering the Liver Microenvironment In the first article of this series, we discussed the limitations of
The liver organoid is transforming how researchers approach drug discovery and safety testing. As miniature, three-dimensional
Understanding how the body processes fats is central to tackling obesity, type 2 diabetes, and fatty
14 rue de la Beaune,
93100 Montreuil (Paris)
France
+33 9 87 04 70 35
contact@cherrybiotech.com
All right reserved to © Cherry Biotech 2023